Curis

$2.04
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.05 (-2.39%) As of 2:17 PM EDT today
-$0.05 (-2.39%) Today

Why Robinhood?

You can buy or sell Curis and other stocks, options, ETFs, and crypto commission-free!

About CRIS

Curis, Inc. engages in the development and commercialization of drug candidates for the treatment of human cancers. Its pipeline includes CUDC-907, CA-4948, CA-170, and CA-327. Read More The CUDC-907 pipeline is an orally available small molecule inhibitor of HDAC and PI3K enzymes. The CA-170 pipeline is an also an orally-available small molecule antagonist of PD-L1 and VISTA immune checkpoints. The company was founded on February 14, 2000 and is headquartered in Lexington, MA.

Employees
31
Headquarters
Lexington, Massachusetts
Founded
2000
Market Cap
69.39M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
151.54K
High Today
$2.07
Low Today
$2.02
Open Price
$2.06
Volume
36.51K
52 Week High
$2.90
52 Week Low
$0.60

Collections

CRIS Earnings

-$0.39
-$0.28
-$0.16
-$0.05
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
Actual
Expected Oct 31, After Hours

Popular Stocks

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.